Help Improve HEDIS, STAR Ratings and HCC Risk Factors by Closing Care Gaps
Intercepting patients during routine primary care office visits with a teleretinal program like the RetinaVue care delivery model can help providers achieve up to 90% documented compliance with diabetic retinal exams in just 12 months.1
That means potential financial incentives from quality programs — and more importantly, the opportunity to help save more patients’ vision. Learn more in our eBook, The Solution is in Sight, The Complete Guide to a Successful Teleretinal Program.
Documented compliance with diabetic retinal exams in just 12 months.1
Help Save Vision for Patients Living with Diabetes in Primary Care
Diabetic Retinopathy is the leading cause of blindness in working-age adults.
95% of vision loss due to diabetic retinopathy can be prevented with early detection.
RetinaVue Care Delivery Model
Help preserve the vision of your patients living with diabetes with a simple eye exam that takes minutes to complete for diabetic retinopathy detection during routine primary care visits. Baxter delivers the three keys to a successful teleretinal program:
Simple and Affordable Hardware
Secure Software Network
Nationwide Services and Support
EMR Connected Workflow
See the RetinaVue 700 Imager in Action
The most advanced handheld retinal camera* in patient-centered retinal imaging technology made for primary care.
60% of diabetic patients or less comply with annual retinal exams2
80% of patients will eventually develop some stage of diabetic retinopathy3
Achieve up to 90% diabetic retinal exam compliance in 12 months1
“The RetinaVue care delivery model helps us take the lead in a quality program that allows more patients to access the diabetic retinal exam in the primary setting. Offering a program that has the potential to prevent vision loss is so important for our patient population. Blindness has a huge impact on the patient and their family/caregiver’s lifestyle and quality of life.”
Dr. Kalyan Gogineni, Director of Value Based Care, Samuel U. Rodgers Health Center
Before it's too late
Watch Monica’s story of losing her vision after diabetic retinopathy was detected too late.
See the Proof
Case Studies and White Papers
*Comparison of specifications of commercially available handheld retinal cameras for the primary care market in the US as of November 12, 2025.
Rx Only: For safe and proper use of the products mentioned herein, please refer to the appropriate Operator’s Manual or Instructions for Use.
References:
1 Mansberger SL, Gleitsmann K, Gardiner S, et al. Comparing the effectiveness of telemedicine and traditional surveillance in providing diabetic retinopathy screening examinations: A randomized controlled trial. Telemed J E Health. 2013 Dec; 19(12): 942-8.
2 Diabetic Retinopathy Preferred Practice Pattern® from the American Academy of Ophthalmology, http://dx.doi.org/10.1016/j.ophtha.2019.09.025, ISSN 0161-6420/1
3 Diabetic Retinopathy Preferred Practice Pattern® from the American Academy of Ophthalmology, http://dx.doi.org/10.1016/j.ophtha.2019.09.025, ISSN 0161-6420/19
Baxter, Hillrom, RetinaVue and Welch Allyn are trademarks of Baxter International Inc. or its subsidiaries.
Any other trademarks, product names or brand images appearing herein are the property of their respective owners.
US-FLC147-240136 (v3.0) 08/2026